|
End-of-day quote
Taipei Exchange
07/09/2026
|
5-day change | 1st Jan Change | ||
| 94.00 TWD | +2.29% |
|
-0.74% | -69.08% |
| Market Cap | 6.28B 199M 171M 161M 147M 275M 18.82B 276M 1.91B 738M 9.64B 747M 731M 30.7B | P/E 2024 |
524x | P/E 2025 | -255x |
|---|---|---|---|---|---|
| Enterprise Value | 3.99B 126M 109M 102M 93.29M 174M 11.95B 175M 1.21B 468M 6.12B 474M 464M 19.49B | EV / Sales 2024 |
1,207x | EV / Sales 2025 | 6,544x |
| Free-Float |
57.17% | Yield 2024 |
0.18% | Yield 2025 | 0.03% |
| 1 day | +2.29% | ||
| 1 week | -0.74% | ||
| Current month | -0.74% | ||
| 1 month | -4.67% | ||
| 3 months | -21.34% | ||
| 6 months | -51.04% | ||
| Current year | -69.08% |
| 1 week | 90.6 |  | 94.1 |
| 1 month | 90.6 | | 105.5 |
| Current year | 90.6 | | 313 |
| 1 year | 90.6 | | 317 |
| 3 years | 90.6 | | 465 |
| 5 years | 42.8 | | 465 |
| 10 years | 42.8 | | 465 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yung Shun Wen
CEO | Chief Executive Officer | - | 22/09/2016 |
Vivian Kang
DFI | Director of Finance/CFO | - | 15/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Lin
CHM | Chairman | - | 22/09/2016 |
Yung Shun Wen
BRD | Director/Board Member | - | 22/09/2016 |
Cheng Yu Fang
BRD | Director/Board Member | - | 06/08/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.29% | -0.74% | -58.22% | -33.33% | 199M | |
| -1.32% | +1.74% | +77.46% | +39.27% | 371B | |
| -0.55% | -2.81% | +23.32% | -19.32% | 68.3B | |
| -0.51% | +3.47% | +47.06% | +181.53% | 12.51B | |
| -0.88% | -11.83% | -8.92% | -9.32% | 8.11B | |
| -1.85% | -2.63% | -22.16% | +5.72% | 4.94B | |
| -0.86% | -3.58% | -32.18% | +18.68% | 4.47B | |
| -1.39% | -4.32% | -34.69% | -0.14% | 3.03B | |
| -1.00% | -1.54% | -5.37% | +44.81% | 2.53B | |
| -0.77% | -2.51% | -24.93% | -16.23% | 1.99B | |
| Average | -0.66% | -1.72% | -3.86% | +21.17% | 47.7B | |
| Weighted average by Cap. | -1.15% | +0.50% | +63.75% | +32.76% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 5.82M 184K 159K 149K 136K 255K 17.44M 255K 1.77M 683K 8.93M 692K 677K 28.44M | 2.75M 87.25K 75.04K 70.58K 64.42K 120K 8.25M 121K 837K 323K 4.23M 328K 321K 13.46M |
| Net income | 18.17M 576K 495K 466K 425K 795K 54.46M 798K 5.52M 2.13M 27.89M 2.16M 2.12M 88.84M | -79.68M -2.53M -2.17M -2.04M -1.86M -3.49M -239M -3.5M -24.22M -9.36M -122M -9.48M -9.28M -390M |
| Net Debt | -2.43B -77.03M -66.25M -62.31M -56.88M -106M -7.28B -107M -739M -286M -3.73B -289M -283M -11.88B | -2.29B -72.67M -62.49M -58.78M -53.66M -100M -6.87B -101M -697M -269M -3.52B -273M -267M -11.21B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/09/26 | NT$94.00 | +2.29% | 45,406 |
| 04/09/26 | NT$91.90 | +1.32% | 27,749 |
| 03/09/26 | NT$90.70 | -0.55% | 36,862 |
| 02/09/26 | NT$91.20 | -1.08% | 46,739 |
| 01/09/26 | NT$92.20 | -2.64% | 92,741 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 6785 Stock
Select your edition
All financial news and data tailored to specific country editions
